Rhinomed
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WARhinomed Limited (RNO) is involved in research, development and commercialisation of consumer and medical devices. Rhinomed is an airway technology company that seeks to radically improve the way people breathe, sleep, maintain their health and take medication.
It finalised design and commenced production of two new products - Pronto Clear and Pronto Sleep. The new Pronto range delivers combined natural stenting of the nose with a proprietary formulation of natural essential oils.
Contact Details
Level 1, 132 Gwynne Street, RICHMOND VIC 3121
03 8416 0900
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 807th |  | Rhinomed | $8.5m |
| 941st | | Applyflow | $2.1m |
| 942nd | | StreamPlay Studio | $2.0m |
| 945th | | NSX | $2.0m |
| 947th | | Latrobe Magnesium | $1.9m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Seab Slattery, Chief Financial Officer and Company Secretary | 24 Nov 2020 |
| NEW ROLE: Shane Duncan, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: Michael Johnson, Chief Executive, Managing Director | 03 Nov 2020 |
| NEW ROLE: Ron R Dewhurst, Non-Executive Chairman, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Brent Scrimshaw, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Eric Knight, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Sean Slattery, Company Secretary | 03 Nov 2020 |
| ECM DEAL: New deal has been added | 14 Jul 2020 |
